{
    "answer": "For Q4 2024: Cosentyx net sales were USD 15,960 million (reported USD 11,457 million, +24% cc). For the full year 2024, Cosentyx's immunology segment sales were presented as $6,390 million (non-adjusted reported) in one source. The full year 2024 immunology segment net sales figures are presented for the Top 20 brands as USD 54,956 million for 2023 and USD 66,740 million for 2024, with the precise reported and constant-currency adjusted figures for Cosentyx specifically in the immunology segment for 2024 not directly available in search snippets.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 4,
    "search count": 3,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        935,
        2270,
        3139,
        4860
    ]
}